| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_af92759c928daeb7f0daabbb0499f059
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b68bb9ba976520aa80fd771645d0934d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d49d1bbee9f8d9841ae0deb6c7e644d8
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c61096aa21f5d28866a972f93ebd0306 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-485
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-5011
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-574 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-574
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-50
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-15
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-48
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-02 |
| filingDate |
2005-05-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_51f2ade1a9cccd2acdf5912316ddcbee
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5743a19d75e3ac6a714d7df80900ce3c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_03550b845ce4a192672f9e5840492097 |
| publicationDate |
2005-12-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2005116241-A1 |
| titleOfInvention |
Method of judging properties of mammalian cell and method of diagnosing cancer |
| abstract |
CDK profile such as the specific activity ratio of two cyclin-dependent kinases closely correlates to the grade of malignancy and the presence/absence of the sensitivity to a stimulating substance such as an anticancer agent of a cancer tissue in clinical medicine. Therefore, the properties of a mammalian cell such as the grade of malignancy of cancer, cell growth ability and the sensitivity to a stimulating substance such as an anticancer agent can be judged based on its CDK profile or by comparing the specific activity ratio of two CDKs with a definite threshold. This sensitivity judgment method shows a high ratio of correct answers particularly in positive sensitivity and is useful in judging the efficacy of an anticancer drug therapy. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11639940-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2028600-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2009072181-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2008220299-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2009089672-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2012228233-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8921114-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2009232815-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2009232816-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2009082109-A |
| priorityDate |
2004-05-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |